(Q38327469)

2 September 2017

The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells (English)

1 reference

2 September 2017

1 reference

Mañes S

1

1 reference

2 September 2017

Llorente M

2

1 reference

2 September 2017

Lacalle RA

3

1 reference

2 September 2017

Gómez-Moutón C

4

1 reference

2 September 2017

Kremer L

5

1 reference

2 September 2017

Mira E

6

1 reference

2 September 2017

Martínez-A C

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

274

1 reference

2 September 2017

6935-6945

1 reference

2 September 2017

11

1 reference

Early signals in the mitogenic response

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Autocrine growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Role of insulin-like growth factors in embryonic and postnatal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Granulosa cell-derived insulin-like growth factor (IGF) binding proteins are inhibitory to IGF-I hormonal action. Evidence derived from the use of a truncated IGF-I analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Role of insulin-like growth factor binding proteins in modifying IGF actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Functional epitope mapping of insulin-like growth factor I (IGF-I) by anti-IGF-I monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

pEF-BOS, a powerful mammalian expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Oncogenes and the strategy of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Insulin-like growth factor expression in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Insulin-like growth factors and their binding proteins: biological actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Interference of the IGF system as a strategy to inhibit breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Monoclonal antibody alpha IR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

The IGF axis in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.11.6935

21 January 2018

Identifiers

DOI

10.1074/JBC.274.11.6935

1 reference

2 September 2017

1 reference